Patrick Trucchio

Stock Analyst at H.C. Wainwright

(4.84)
# 442
Out of 5,136 analysts
1190
Total ratings
43.8%
Success rate
19.5%
Average return

Stocks Rated by Patrick Trucchio

AgomAb Therapeutics NV
Nov 16, 2026
Reiterated: Buy
Price Target: $35
Current: $5.97
Upside: +486.26%
Faeth Therapeutics
Nov 16, 2026
Reiterated: Buy
Price Target: $60
Current: $9.28
Upside: +546.55%
Gossamer Bio
Nov 16, 2026
Reiterated: Buy
Price Target: $90
Current: $10.98
Upside: +719.67%
Voyager Therapeutics
Nov 16, 2026
Reiterated: Buy
Price Target: $25
Current: $1.63
Upside: +1,433.74%
Alto Neuroscience
Nov 12, 2026
Reiterated: Buy
Price Target: $60
Current: $27.12
Upside: +121.24%
Harmony Biosciences Holdings
Nov 12, 2026
Reiterated: Buy
Price Target: $55
Current: $32.96
Upside: +66.87%
Oncolytics Biotech
Nov 12, 2026
Reiterated: Buy
Price Target: $5
Current: $0.3399
Upside: +1,371.02%
Aligos Therapeutics
Nov 11, 2026
Reiterated: Buy
Price Target: $50
Current: $1.66
Upside: +2,912.05%
Alnylam Pharmaceuticals
Nov 11, 2026
Reiterated: Buy
Price Target: $455
Current: $159.73
Upside: +184.86%
Altimmune
Nov 11, 2026
Reiterated: Buy
Price Target: $20
Current: $1.56
Upside: +1,182.05%
Reiterated: Buy
Price Target: $120
Current: $44.21
Upside: +171.43%
Reiterated: Buy
Price Target: $50
Current: $21.29
Upside: +134.85%
Reiterated: Buy
Price Target: $80
Current: $20.94
Upside: +282.04%
Reiterated: Buy
Price Target: $60
Current: $7.28
Upside: +724.18%
Reiterated: Buy
Price Target: $100 → $80
Current: $28.88
Upside: +177.01%
Reiterated: Buy
Price Target: $22
Current: $9.58
Upside: +129.65%
Reiterated: Buy
Price Target: $65
Current: $8.27
Upside: +685.97%
Reiterated: Buy
Price Target: $70
Current: $30.16
Upside: +132.10%
Reiterated: Buy
Price Target: $65
Current: $18.75
Upside: +246.67%
Reiterated: Buy
Price Target: $45
Current: $2.15
Upside: +1,993.02%
Reiterated: Buy
Price Target: $80
Current: $21.88
Upside: +265.63%
Reiterated: Buy
Price Target: $145
Current: $22.61
Upside: +541.31%
Downgraded: Hold
Price Target: $75 → $20
Current: $19.80
Upside: +1.01%
Reiterated: Buy
Price Target: $60
Current: $32.44
Upside: +84.96%
Reiterated: Buy
Price Target: $10
Current: $0.5377
Upside: +1,759.77%
Reiterated: Buy
Price Target: $10
Current: $0.8286
Upside: +1,106.85%
Rated: Hold
Price Target: n/a
Current: $0.1089
Upside: -
Reiterated: Buy
Price Target: $25 → $10
Current: $0.365
Upside: n/a
Reiterated: Buy
Price Target: $20 → $360
Current: $8.29
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $8.54
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $0.05
Upside: n/a
Reiterated: Buy
Price Target: 100p → 46p
Current: 1p
Upside: n/a
Reiterated: Buy
Price Target: €33.00
Current: €2.94
Upside: n/a
Reiterated: Buy
Price Target: $120 → $130
Current: $10.67
Upside: n/a
Downgraded: Hold
Price Target: $117 → $72
Current: $16.18
Upside: n/a
Initiated Coverage: Buy
Price Target: $22
Current: $18.49
Upside: n/a
Initiated Coverage: Buy
Price Target: $25
Current: $4.85
Upside: n/a
Upgraded: Buy
Price Target: $125
Current: $111.34
Upside: n/a